Press release
Adrenocorticotropic Hormone (ACTH) Market Size to be Worth USD 1.91 million by 2031, with Notable CAGR of 3.9%| TMR
The Adrenocorticotropic Hormone (ACTH) market is set to witness significant growth, with a projected value exceeding US$ 1.91 billion by 2031. This anticipated expansion, at a Compound Annual Growth Rate (CAGR) of 3.9% from 2021 to 2031, is indicative of the burgeoning importance of ACTH in the medical and healthcare sectors. In this article, we delve into various facets of the ACTH market, including market size, growth drivers, segmentation, challenges, and emerging trends.Market Overview: A comprehensive market overview sheds light on the key players, market dynamics, and competitive landscape. Understanding the market's current state is crucial for stakeholders aiming to make informed decisions and capitalize on emerging opportunities.
Are you interested in gaining deeper insights into the ACTH market? Request your sample copy of the latest report to access comprehensive data and analysis: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=76241
Companies Profiled
• Ambio Pharm, Inc.
• Armor Pharma
• Avantor, Inc.
• BCN Peptides S.A.
• BIOVECTRA
• Ferring B.V.
• Hikma Pharmaceuticals plc
• Mallinckrodt Pharmaceuticals
• Merck KGaA
• Novartis AG
• Novus Biologicals
• Pfizer, Inc.
• Piramal Pharma Solutions
• PolyPeptide Group
• SAJJALA BIO LABS
• Sichuan Xieli Pharmaceutical Co., Ltd.
• Viatris, Inc.
For Customization of this Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=76241
Market Drivers: Several factors contribute to the growth of the ACTH market. One primary driver is the rising prevalence of disorders related to the adrenal glands, where ACTH plays a pivotal role in regulation. Additionally, the increasing awareness among healthcare professionals regarding the therapeutic benefits of ACTH further propels market growth.
Latest Market Trends: The ACTH market is dynamic, with evolving trends shaping its trajectory. From innovative therapeutic approaches to advancements in production techniques, staying abreast of the latest trends is vital for market participants. Continuous monitoring allows stakeholders to adapt their strategies and maintain a competitive edge.
Future Outlook and Recent Developments:
The future outlook of the ACTH market is promising, driven by ongoing research and development initiatives. Recent developments in treatment modalities, product launches, and strategic collaborations contribute to the market's growth trajectory. A forward-looking perspective helps stakeholders prepare for emerging opportunities and challenges.
Adrenocorticotropic Hormone (ACTH) Market - Segmentation
Source: Natural, Synthetic
Indication: Rheumatology, Neurology, Nephrotic Syndrome, Ophthalmology, Others
Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Region
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
Delve deeper into the ACTH market's intricacies by exploring the comprehensive Table of Contents (TOC) of the report: https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=76241
Market Opportunities and Demand:
Identifying market opportunities and understanding demand dynamics is crucial for stakeholders seeking a competitive advantage. The ACTH market presents numerous opportunities for innovation, collaboration, and market expansion. Analyzing demand patterns helps companies tailor their strategies to meet the evolving needs of the market.
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact:
Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Adrenocorticotropic Hormone (ACTH) Market Size to be Worth USD 1.91 million by 2031, with Notable CAGR of 3.9%| TMR here
News-ID: 3365015 • Views: …
More Releases from Transparency Market Research
Functional Coffee Market Expanding at 7.6% CAGR Through 2035 - By Product Type / …
The global functional coffee market was valued at US$ 21.5 Bn in 2024 and is projected to reach US$ 48.1 Bn by 2035, expanding at a compound annual growth rate (CAGR) of 7.6% from 2025 to 2035. This steady growth trajectory reflects the strong convergence of coffee consumption habits with rising demand for functional and wellness-oriented beverages. Functional coffee has transitioned from a niche category to a mainstream product offering,…
Global Electric Face Cleanser Market Poised for Robust Growth, projected to Reac …
The global electric face cleanser market is witnessing a transformative growth phase as consumers increasingly integrate advanced skincare technologies into their daily routines. Valued at USD 9.8 billion in 2025, the market is projected to expand significantly and reach USD 23.6 billion by 2036, growing at a healthy compound annual growth rate (CAGR) of 8.6% from 2026 to 2036. This growth trajectory underscores the rising importance of personal care technology,…
Asthma and COPD Drugs Market to Reach US$ 82.2 Billion by 2036, Growing at 5.7% …
The global asthma and COPD drugs market demonstrated strong fundamentals in 2025, with a valuation of US$ 44.7 Bn, reflecting the essential and recurring nature of respiratory therapeutics. Supported by a growing patient base and continuous pharmaceutical innovation, the market is projected to reach US$ 82.2 Bn by 2036, expanding at a compound annual growth rate (CAGR) of 5.7% from 2026 to 2036.
This growth trajectory highlights the increasing reliance on…
Low-Alcohol Beverages Market Outlook 2035: Global Industry Set to Expand from US …
The global low-alcohol beverages market is undergoing a structural transformation as consumers increasingly prioritize health, moderation, and mindful drinking without sacrificing taste or social experiences. Valued at US$ 2.1 billion in 2024, the market is projected to reach US$ 4.6 billion by 2035, expanding at a healthy CAGR of 7.5% from 2025 to 2035. This sustained growth reflects changing lifestyle preferences, generational shifts in alcohol consumption, and continuous innovation by…
More Releases for ACTH
ACTH ELISA Test Kit Market Key Players, Share and Forecast Outlook
"The global market for ACTH ELISA test kits is valued at approximately $150 million in 2024, with a projected value of around $280 million by 2034. This represents a Compound Annual Growth Rate (CAGR) of approximately 6.5% during the forecast period from 2025 to 2034. "
Exactitude Consultancy., Ltd. released a research report titled "ACTH ELISA Test Kit Market". This report covers the global ACTH ELISA Test Kit market sales, sales…
Innovative Horizons in the ACTH (1-39) Market: Trends and Leading Players
In today's dynamic global economy, the ACTH (1-39) market is emerging as a beacon of opportunity and innovation. With rapid technological advancements, evolving consumer demands, and proactive government policies shaping the landscape, this sector is setting the stage for transformative change. Our in-depth analysis delves into historical market trends, current dynamics, and future projections, providing industry leaders, investors, and decision-makers with the strategic insights needed to navigate this competitive terrain.
𝐆𝐞𝐭…
ACTH Deficiency Market is growing at a healthy CAGR 7.00% by 2028
Global ACTH Deficiency market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market is growing at a healthy CAGR 7.00% in the above-mentioned research forecast period. Rising prevalence of rare disorders such as Addison Disease, Gigantism, Cushing Syndrome, Childhood Obesity and others are the factors responsible for the growth of this market.
However, a rising population with unhealthy lifestyles…
Adrenocorticotropic Hormone [ACTH] Market to Record an Exponential CAGR by 2031
Adrenocorticotropic Hormone (ACTH) Market: Introduction
According to the report, the global adrenocorticotropic hormone (ACTH) market was valued at US$ 1.3 Bn in 2020 and is projected to expand at a CAGR of 3.9% from 2021 to 2031. Need for the development of newer and technologically enhanced products is rising globally, owing to treatment efficiency of drugs. Hence, major players operating in the market invest in research & development in order to develop new drugs. The rise in…
Adrenocorticotropic Hormone (ACTH) Market 2022: Mallinckrodt, Pfizer, Novartis A …
Adrenocorticotropic Hormone (ACTH) Market research report studies the competitive development of the market, such as agreements, new product launches, expansions, and acquisitions in the market. In addition, it provides a region-wise study of the market, including North America, Asia Pacific, Latin America, the Middle East, Africa, and Europe. As a result, it helps stakeholders understand market players and analyze the top 25 organizations based on their product footprint, market strength,…
ACTH Deficiency Treatment Market Analysis & Key Business Strategies by Leading I …
Adenocorticotropic hormone (ACTH) is produced and secreted by anterior pituitary gland. It is also called corticotropin, serum ACTH, etc. The hormone’s function is to regulate the levels of steroid hormone cortisol which is regulated by adrenal gland. ACTH is associated with diseases such as pituitary tumors and adrenal malfunctions. Deficiency of ACTH arises due to the absence or decreased production of adrenocorticotropic hormone, which leads to adrenal insufficiency. This results…
